Simon W. Rabkin - Publications

Affiliations: 
University of British Columbia, Vancouver, Vancouver, BC, Canada 
Area:
Medicine and Surgery, Cell Biology, Animal Physiology Biology

102 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Rabkin SW, Tang JKK. The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review. Heart Failure Reviews. PMID 32472523 DOI: 10.1007/S10741-020-09913-3  0.312
2019 Tang JKK, Rabkin SW. Determination of the QT Interval in Left Bundle Branch Block: Development of a Novel Formula. The Canadian Journal of Cardiology. 35: 855-865. PMID 31292084 DOI: 10.1016/J.Cjca.2019.02.014  0.309
2019 Warbrick I, Rabkin SW. Effect of the peptides Relaxin, Neuregulin, Ghrelin and Glucagon-like peptide-1, on cardiomyocyte factors involved in the molecular mechanisms leading to diastolic dysfunction and/or heart failure with preserved ejection fraction. Peptides. 111: 33-41. PMID 29807087 DOI: 10.1016/J.Peptides.2018.05.009  0.317
2018 Nouraei H, Bennett M, Rabkin S. Value of the New Spline QTc Formula in Adjusting for Pacing-Induced Changes in Heart Rate. Cardiology Research and Practice. 2018: 2052601. PMID 29805797 DOI: 10.1155/2018/2052601  0.302
2018 Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, ... ... Rabkin SW, et al. Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. The Canadian Journal of Cardiology. 34: 506-525. PMID 29731013 DOI: 10.1016/J.Cjca.2018.02.022  0.346
2018 Khan NA, Rabkin SW, Zhao Y, McAlister FA, Park JE, Guan M, Chan S, Humphries KH. Effect of Lowering Diastolic Pressure in Patients With and Without Cardiovascular Disease: Analysis of the SPRINT (Systolic Blood Pressure Intervention Trial). Hypertension (Dallas, Tex. : 1979). PMID 29581214 DOI: 10.1161/Hypertensionaha.117.10177  0.345
2018 Yim J, Rabkin SW. A patient-specific approach to assessing blood pressure management in patients with hypertension and coronary artery disease. Journal of Clinical Hypertension (Greenwich, Conn.). PMID 29370480 DOI: 10.1111/Jch.13191  0.311
2017 Rabkin SW. Criteria for short QT interval based on a new QT-heart rate adjustment formula. Journal of Arrhythmia. 33: 525-527. PMID 29021866 DOI: 10.1016/J.Joa.2017.04.004  0.331
2017 Rabkin SW. Is Reduction in Coronary Blood Flow the Mechanism by Which Epicardial Fat Produces Left Ventricular Diastolic Dysfunction Canadian Journal of Cardiology. 33: 1459-1461. PMID 28974325 DOI: 10.1016/J.Cjca.2017.08.013  0.307
2017 Leung AA, Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, Nerenberg K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, ... ... Rabkin SW, et al. Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. The Canadian Journal of Cardiology. 33: 557-576. PMID 28449828 DOI: 10.1016/J.Cjca.2017.03.005  0.36
2017 Khan N, Zhao Y, Rabkin S, Izadnegahdar M, Park J, Guan M, Lee M, Grubisic M, Peng D, Daniele P, Chan S, Humphries K. How Low Is Too Low? Analysis Of Systolic And Diastolic Blood Pressure In Patients With And Without Prior Cardiovascular Disease In The Sprint Trial Canadian Journal of Cardiology. 33. DOI: 10.1016/J.Cjca.2017.07.391  0.311
2016 Rabkin SW, Cheng XJ, Thompson DJ. Detailed analysis of the impact of age on the QT interval. Journal of Geriatric Cardiology : Jgc. 13: 740-748. PMID 27899938 DOI: 10.11909/J.Issn.1671-5411.2016.09.013  0.312
2016 Rabkin SW. Considerations in understanding the coronary blood flow- left ventricular mass relationship in patients with hypertension. Current Cardiology Reviews. PMID 27633073 DOI: 10.2174/1573397112666160909093642  0.325
2016 Rabkin SW. Target blood pressure for patients with hypertension: lower blood pressure is not better Journal of the American Society of Hypertension. 10: 623-624. PMID 27514652 DOI: 10.1016/J.Jash.2016.06.034  0.329
2016 Rabkin SW, Shiekh IA, Wood DA. The Impact of Left Ventricular Mass on Diastolic Blood Pressure Targets for Patients With Coronary Artery Disease. American Journal of Hypertension. PMID 27312942 DOI: 10.1093/Ajh/Hpw044  0.337
2016 Leung AA, Nerenberg K, Daskalopoulou SS, McBrien K, Zarnke KB, Dasgupta K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tobe SW, Ruzicka M, ... ... Rabkin SW, et al. Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. The Canadian Journal of Cardiology. 32: 569-88. PMID 27118291 DOI: 10.1016/J.Cjca.2016.02.066  0.333
2015 Rabkin SW. Impact of Age and Sex on QT Prolongation in Patients Receiving Psychotropics. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 60: 206-14. PMID 26174524 DOI: 10.1177/070674371506000502  0.338
2015 Rabkin SW, Cheng XB. Nomenclature, categorization and usage of formulae to adjust QT interval for heart rate. World Journal of Cardiology. 7: 315-25. PMID 26131336 DOI: 10.4330/Wjc.V7.I6.315  0.303
2015 Rabkin SW, Moe G. The case against using hypertension as the only criterion for oral anticoagulation in atrial fibrillation. The Canadian Journal of Cardiology. 31: 576-9. PMID 25936484 DOI: 10.1016/J.Cjca.2015.03.022  0.312
2015 Daskalopoulou SS, Rabi DM, Zarnke KB, Dasgupta K, Nerenberg K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, McKay DW, Tremblay G, McLean D, Tobe SW, Ruzicka M, ... ... Rabkin SW, et al. The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. The Canadian Journal of Cardiology. 31: 549-68. PMID 25936483 DOI: 10.1016/J.Cjca.2015.02.016  0.316
2015 Klimas J, Kruzliak P, Rabkin SW. Modulation of the QT interval duration in hypertension with antihypertensive treatment. Hypertension Research : Official Journal of the Japanese Society of Hypertension. 38: 447-54. PMID 25787045 DOI: 10.1038/Hr.2015.30  0.369
2014 Dvorakova MC, Kruzliak P, Rabkin SW. Role of neuropeptides in cardiomyopathies. Peptides. 61: 1-6. PMID 25149360 DOI: 10.1016/J.Peptides.2014.08.004  0.304
2013 Rabkin SW. Differences in coronary blood flow in aortic regurgitation and systemic arterial hypertension have implications for diastolic blood pressure targets: a systematic review and meta-analysis. Clinical Cardiology. 36: 728-36. PMID 24037941 DOI: 10.1002/Clc.22194  0.338
2013 Chow B, Rabkin SW. Brachial-ankle pulse wave velocity is the only index of arterial stiffness that correlates with a mitral valve indices of diastolic dysfunction, but no index correlates with left atrial size. Cardiology Research and Practice. 2013: 986847. PMID 23533943 DOI: 10.1155/2013/986847  0.317
2012 Rabkin SW, Chan SH. Correlation of pulse wave velocity with left ventricular mass in patients with hypertension once blood pressure has been normalized. Heart International. 7: e5. PMID 22690298 DOI: 10.4081/Hi.2012.E5  0.336
2012 Daskalopoulou SS, Khan NA, Quinn RR, Ruzicka M, McKay DW, Hackam DG, Rabkin SW, Rabi DM, Gilbert RE, Padwal RS, Dawes M, Touyz RM, Campbell TS, Cloutier L, Grover S, et al. The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. The Canadian Journal of Cardiology. 28: 270-87. PMID 22595447 DOI: 10.1016/J.Cjca.2012.02.018  0.346
2012 Rabkin SW, Waheed A, Wood D. 511 Myocardial Perfusion Pressure In Patients With Hypertension And Coronary Artery Disease: Implications For Diastolic Blood Pressure Targets In Hypertension Management Journal of Hypertension. 30. DOI: 10.1097/01.Hjh.0000420804.74914.Fb  0.325
2012 Rabkin SW, Waheed A, Wood D. 499 Myocardial Perfusion Pressure in Patients With Coronary Artery Disease and Hypertension With and Without Diabetes Mellitus: Implications for Diastolic Blood Pressure Targets in Hypertension Management Canadian Journal of Cardiology. 28. DOI: 10.1016/J.Cjca.2012.07.456  0.327
2011 Rabi DM, Daskalopoulou SS, Padwal RS, Khan NA, Grover SA, Hackam DG, Myers MG, McKay DW, Quinn RR, Hemmelgarn BR, Cloutier L, Bolli P, Hill MD, Wilson T, Penner B, ... ... Rabkin SW, et al. The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. The Canadian Journal of Cardiology. 27: 415-433.e1-2. PMID 21801975 DOI: 10.1016/J.Cjca.2011.03.015  0.326
2011 Rabkin SW. Endothelin but Not Angiotensin II May Mediate Hypertension-Induced Coronary Vascular Calcification in Chronic Kidney Disease. International Journal of Nephrology. 2011: 516237. PMID 21747998 DOI: 10.4061/2011/516237  0.303
2009 Rabkin SW, Lodhia P, Lodha P. Stearic acid-induced cardiac lipotoxicity is independent of cellular lipid and is mitigated by the fatty acids oleic and capric acid but not by the PPAR agonist troglitazone. Experimental Physiology. 94: 877-87. PMID 19482900 DOI: 10.1113/Expphysiol.2009.048082  0.314
2009 Rabkin SW, Klassen SS. Jumonji is a potential regulatory factor mediating nitric oxide-induced modulation of cardiac hypertrophy. Journal of Cardiovascular Medicine (Hagerstown, Md.). 10: 206-11. PMID 19194181 DOI: 10.2459/Jcm.0B013E3283212Ecd  0.331
2009 Klassen SS, Rabkin SW. The metalloporphyrin FeTPPS but not by cyclosporin A antagonizes the interaction of peroxynitrate and hydrogen peroxide on cardiomyocyte cell death. Naunyn-Schmiedeberg's Archives of Pharmacology. 379: 149-61. PMID 18773197 DOI: 10.1007/S00210-008-0342-3  0.307
2009 Rabkin SW. Apoptosis in Human Acute Myocardial Infarction: The Rationale for Clinical Trials of Apoptosis Inhibition in Acute Myocardial Infarction Scholarly Research Exchange. 2009: 1-10. DOI: 10.3814/2009/979318  0.306
2008 Padwal RS, Hemmelgarn BR, Khan NA, Grover S, McAlister FA, McKay DW, Wilson T, Penner B, Burgess E, Bolli P, Hill MD, Mahon J, Myers MG, Abbott C, Schiffrin EL, ... ... Rabkin SW, et al. The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk. The Canadian Journal of Cardiology. 24: 455-63. PMID 18548142 DOI: 10.1016/S0828-282X(08)70619-6  0.323
2008 Rabkin SW, Tsang MY. The action of nitric oxide to enhance cell survival in chick cardiomyocytes is mediated through a cGMP and ERK1/2 pathway while p38 mitogen-activated protein kinase-dependent pathways do not alter cell death. Experimental Physiology. 93: 834-42. PMID 18344257 DOI: 10.1113/Expphysiol.2008.042176  0.305
2008 Rabkin SW, Klassen SS. Palmitate-induced NO production has a dual action to reduce cell death through NO and accentuate cell death through peroxynitrite formation. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 78: 147-55. PMID 18191557 DOI: 10.1016/J.Plefa.2007.09.003  0.316
2007 Rabkin SW, Lodha P, Kong JY. Reduction of protein synthesis and statin-induced cardiomyocyte cell death. Cardiovascular Toxicology. 7: 1-9. PMID 17646677 DOI: 10.1007/S12012-007-0003-7  0.301
2007 Klassen SS, Rabkin SW. The role of p53 in nitric oxide-induced cardiomyocyte cell death. Dna and Cell Biology. 26: 465-75. PMID 17630850 DOI: 10.1089/Dna.2007.0576  0.311
2007 Rabkin SW. Nitric oxide-induced cell death in the heart: the role of autophagy. Autophagy. 3: 347-9. PMID 17438363 DOI: 10.4161/Auto.4054  0.34
2007 Rabkin SW, Klassen SS. Omapatrilat enhances adrenomedullin's reduction of cardiomyocyte cell death. European Journal of Pharmacology. 562: 174-82. PMID 17343842 DOI: 10.1016/J.Ejphar.2007.01.056  0.31
2004 Kong JY, Rabkin SW. Reduction of palmitate-induced cardiac apoptosis by fenofibrate. Molecular and Cellular Biochemistry. 258: 1-13. PMID 15030165 DOI: 10.1023/B:Mcbi.0000012811.89386.A8  0.327
2003 Rabkin SW, Kong JY. Lovastatin-induced cardiac toxicity involves both oncotic and apoptotic cell death with the apoptotic component blunted by both caspase-2 and caspase-3 inhibitors. Toxicology and Applied Pharmacology. 193: 346-55. PMID 14678744 DOI: 10.1016/J.Taap.2003.08.009  0.31
2002 Rabkin SW. Fumonisin blunts nitric oxide-induced and nitroprusside-induced cardiomyocyte death. Nitric Oxide : Biology and Chemistry / Official Journal of the Nitric Oxide Society. 7: 229-35. PMID 12446171 DOI: 10.1016/S1089-8603(02)00115-5  0.312
2002 Kong JY, Rabkin SW. Palmitate-induced cardiac apoptosis is mediated through CPT-1 but not influenced by glucose and insulin. American Journal of Physiology. Heart and Circulatory Physiology. 282: H717-25. PMID 11788422 DOI: 10.1152/Ajpheart.00257.2001  0.312
2000 Kong JY, Rabkin SW. Palmitate-induced apoptosis in cardiomyocytes is mediated through alterations in mitochondria: prevention by cyclosporin A. Biochimica Et Biophysica Acta. 1485: 45-55. PMID 10802248 DOI: 10.1016/S1388-1981(00)00028-7  0.319
2000 Rabkin SW, Kong JY. Nifedipine does not induce but rather prevents apoptosis in cardiomyocytes. European Journal of Pharmacology. 388: 209-217. PMID 10675728 DOI: 10.1016/S0014-2999(99)00880-8  0.311
1999 Kong JY, Rabkin SW. Thapsigargin Enhances Camptothecin‐Induced Apoptosis in Cardiomyocytes Pharmacology & Toxicology. 85: 212-220. PMID 10608483 DOI: 10.1111/J.1600-0773.1999.Tb02011.X  0.313
1997 Goutsouliak V, Rabkin SW. Angiotensin II-Induced Inositol Phosphate Generation is Mediated Through Tyrosine Kinase Pathways in Cardiomyocytes Cellular Signalling. 9: 505-512. PMID 9419814 DOI: 10.1016/S0898-6568(97)00008-9  0.304
1997 Hao JM, Rabkin SW. Increased cardiac ppENK mRNA in cardiac hypertrophy and effects on blood pressure of its peptide products American Journal of Physiology-Heart and Circulatory Physiology. 272. PMID 9227569 DOI: 10.1152/Ajpheart.1997.272.6.H2885  0.375
1996 Rabkin SW, Damen JE, Goutsouliak V, Krystal G. Cardiac hypertrophy in the Dahl rat is associated with increased tyrosine phosphorylation of several cytosolic proteins, including a 120 kDa protein. American Journal of Hypertension. 9: 230-6. PMID 8695021 DOI: 10.1016/0895-7061(95)00382-7  0.325
1994 Rabkin SW. Indapamide alters the cyclic AMP signal transduction pathway in cardiomyocytes in culture European Journal of Pharmacology. 266: 117-123. PMID 8157065 DOI: 10.1016/0922-4106(94)90100-7  0.335
1994 Rabkin SW, Freestone N, Quamme GA. Nifedipine does not alter the increased cystolic free magnesium during inhibition of mitochondrial function in isolated cardiac myocytes General Pharmacology-the Vascular System. 25: 1483-1491. PMID 7896064 DOI: 10.1016/0306-3623(94)90178-3  0.335
1994 Sunga PS, Rabkin SW. Angiotensin II induced alteration of cyclic adenosine 3′,5′-monophosphate generation in the hypertrophic myocardium of Dahl salt-sensitive rat on a high-salt diet Canadian Journal of Physiology and Pharmacology. 72: 602-612. PMID 7525030 DOI: 10.1139/Y94-086  0.333
1994 Rabkin SW. Verapamil has antiarrhythmic effects that are mediated in brain through endogenous opioids. Journal of Cardiovascular Pharmacology. 23: 814-821. PMID 7521466 DOI: 10.1097/00005344-199405000-00018  0.347
1993 Rabkin SW. The opioid agonist ethylketocyclazocine accentuates epinephrine-induced cardiac arrhythmias in the rat through an action in the brain Brain Research Bulletin. 31: 427-432. PMID 8490741 DOI: 10.1016/0361-9230(93)90236-5  0.34
1993 Rabkin SW. Lisinopril increases the recovery during reoxygenation and resistance to oxidative damage in cardiomyocytes European Journal of Pharmacology. 238: 81-88. PMID 8405086 DOI: 10.1016/0014-2999(93)90508-F  0.328
1993 Rabkin SW. Comparative effects on blood pressure and heart rate of dynorphin A(1-13) in anterior hypothalamic area, posterior hypothalamic area, nucleus tractus solitarius, and lateral cerebral ventricle in the rat. Peptides. 14: 1253-1258. PMID 7907790 DOI: 10.1016/0196-9781(93)90184-I  0.367
1993 Rabkin SW. Comparison of indapamide and hydrochlorothiazide on spontaneous contraction of cardiomyocytes in culture: the effect on alterations of extracellular calcium or potassium. General Pharmacology-the Vascular System. 24: 699-704. PMID 7689999 DOI: 10.1016/0306-3623(93)90234-O  0.326
1993 Rabkin SW. Verapamil in the Brain Lowers Blood Pressure and Heart Rate Independent of Central Muscarinic Receptors Hypertension Research. 16: 97-103. DOI: 10.1291/Hypres.16.97  0.374
1993 Rabkin SW. Effect of indapamide on cyclic adenosine 3',5'-monophosphate signal transduction system in isolated adult rat cardiomyocytes from normal myocardium and cardiac hypertrophy Journal of Cardiovascular Pharmacology. 22: 35-41. DOI: 10.1097/00005344-199306226-00007  0.331
1992 Sunga PS, Rabkin SW. Angiotensin II-induced protein phosphorylation in the hypertrophic heart of the Dahl rat. Hypertension. 20: 633-642. PMID 1428115 DOI: 10.1161/01.Hyp.20.5.633  0.311
1992 Rabkin SW. Cilazapril and captopril accelerate recovery from hypoxia in myocardial cell aggregates in culture. Journal of Cardiovascular Pharmacology. 19: 394-401. PMID 1378120 DOI: 10.1097/00005344-199203000-00015  0.339
1992 Rabkin SW. Morphine and the endogenous opioid dynorphin in the brain attenuate digoxin-induced arrhythmias in guinea pigs. Pharmacology & Toxicology. 71: 353-360. PMID 1360157 DOI: 10.1111/J.1600-0773.1992.Tb00561.X  0.323
1992 Rabkin SW. Dynorphin A (1-13) in the brain suppresses epinephrine-induced ventricular premature complexes and ventricular tachyarrhythmias. Regulatory Peptides. 41: 95-107. PMID 1279757 DOI: 10.1016/0167-0115(92)90039-W  0.356
1991 Rabkin SW. Diltiazem and verapamil lower blood pressure in the unanaesthetized rat through CNS mechanisms involving endogenous opioids. Clinical and Experimental Pharmacology and Physiology. 18: 431-438. PMID 1914246 DOI: 10.1111/J.1440-1681.1991.Tb01475.X  0.349
1991 Rabkin SW. d-Ala-2-Me-Phe-4-Met-(O)-ol-enkephalin in the nucleus tractus solitarius of the rat produces cardiorespiratory depression General Pharmacology-the Vascular System. 22: 479-484. PMID 1869020 DOI: 10.1016/0306-3623(91)90009-U  0.323
1991 Sunga PS, Rabkin SW. Reversal of angiotensin II effect on the cyclic adenosine 3′,5′ monophosphate response to isoprenaline in cardiac hypertrophy Cardiovascular Research. 25: 965-968. PMID 1667504 DOI: 10.1093/Cvr/25.11.965  0.331
1991 Rabkin SW. Angiotensin in the brain suppresses epinephrine-induced cardiac arrhythmias through CNS opioid mechanisms Life Sciences. 49: 1183-1190. PMID 1654493 DOI: 10.1016/0024-3205(91)90566-T  0.336
1990 Rabkin SW. Effect of amiodarone and desethylamiodarone on choline uptake and phosphatidylchoine biosynthesis in cultured chick cardiac myocytes Journal of Molecular and Cellular Cardiology. 22: 965-974. PMID 2280415 DOI: 10.1016/0022-2828(90)91036-7  0.309
1990 Rabkin SW. The effect of amiloride on the cardiac chronotropic responses to isoproterenol in myocardial aggregate cells in culture. Pharmacology & Toxicology. 67: 109-114. PMID 2255661 DOI: 10.1111/J.1600-0773.1990.Tb00794.X  0.333
1990 Rabkin SW. The effect of alteration of extracellular Na+ or Ca2+ and inhibition of Ca2+ entry, Na(+)-H+ exchange, and Na(+)-Ca2+ exchange by diltiazem, amiloride, and dichlorobenzamil on the response of cardiac cell aggregates to epidermal growth factor. Experimental Cell Research. 188: 262-266. PMID 2159405 DOI: 10.1016/0014-4827(90)90168-A  0.315
1989 Rabkin SW. Effect of D-Ala-2-Me-Phe-4-Gly-ol-5 enkephalin on epinephrine-induced arrhythmias in the rat and the interrelationship to the parasympathetic nervous system Life Sciences. 45: 1039-1047. PMID 2796596 DOI: 10.1016/0024-3205(89)90160-4  0.304
1989 Rabkin SW. Effects of chlorpromazine and trifluoperazine on choline metabolism and phosphatidylcholine biosynthesis in cultured chick heart cells under normoxic and anoxic conditions. Biochemical Pharmacology. 38: 2349-2355. PMID 2751698 DOI: 10.1016/0006-2952(89)90475-9  0.332
1989 Rabkin SW, Redston M. The effect of inhibitors of endogenous opioid degradation, bacitracin, bestatin, captopril, and D-phenylalanine, on digoxin-induced arrhythmias in guinea pigs. Canadian Journal of Physiology and Pharmacology. 67: 857-863. PMID 2688852 DOI: 10.1139/Y89-134  0.306
1989 Rabkin SW. The effect of amiloride and its analog dichlorobenzamil on the cardiac chronotropic responses of myocardial cell aggregates in culture to alterations of extracellular potassium or calcium. General Pharmacology-the Vascular System. 20: 595-600. PMID 2606327 DOI: 10.1016/0306-3623(89)90092-X  0.321
1988 Sunga PS, Pritchard PH, Rabkin SW. Effect of cAMP on choline uptake and phosphatidylcholine biosynthesis in cultured chick heart cells. Biochemistry and Cell Biology. 66: 231-237. PMID 2838058 DOI: 10.1139/O88-030  0.327
1987 Rabkin SW. The effect of D-Ala-2-Me-Phe-4-Met-(O)-OL enkephalin on blood pressure, heart rate and digoxin-induced arrhythmias in the guinea pig Life Sciences. 41: 1109-1116. PMID 3613866 DOI: 10.1016/0024-3205(87)90628-X  0.354
1987 Rabkin SW, Sunga P. The effect of Doxorubicin (adriamycin) on cytoplasmic microtubule system in cardiac cells Journal of Molecular and Cellular Cardiology. 19: 1073-1083. PMID 3325651 DOI: 10.1016/S0022-2828(87)80352-8  0.301
1987 Rabkin SW, Roob O. Effect of chronic diuretics on epinephrine-induced ventricular arrhythmias: a comparison of hydrochlorothiazide and amiloride in the rat. Journal of Cardiovascular Pharmacology. 10: 238-245. PMID 2441176 DOI: 10.1097/00005344-198708000-00015  0.328
1987 Rabkin SW. Effect of chlorpromazine on myocardial damage in the calcium paradox. Journal of Cardiovascular Pharmacology. 9: 486-492. PMID 2438512 DOI: 10.1097/00005344-198704000-00014  0.352
1985 Tomlinson CW, Godin DV, Rabkin SW. Adriamycin cardiomyopathy: Implications of cellular changes in a canine model with mild impairment of left ventricular function☆ Biochemical Pharmacology. 34: 4033-4041. PMID 2998397 DOI: 10.1016/0006-2952(85)90384-3  0.336
1984 Rabkin SW, Desjardins P. Mitochondrial and cytoplasmic isoenzymes of aspartate aminotransferase in sera of patients after myocardial infarction. Clinica Chimica Acta. 138: 245-257. PMID 6723062 DOI: 10.1016/0009-8981(84)90131-1  0.307
1984 Rabkin SW. Electrocardiographic abnormalities in apparently healthy men and the risk of sudden death. Drugs. 28: 28-45. PMID 6209083 DOI: 10.2165/00003495-198400281-00004  0.352
1984 Fung AYM, Rabkin SW. Beneficial effects of streptokinase on left ventricular function after myocardial reoxygenation and reperfusion following global ischemia in the isolated rabbit heart. Journal of Cardiovascular Pharmacology. 6: 429-435. PMID 6202968 DOI: 10.1097/00005344-198405000-00009  0.323
1983 Rabkin SW. Interaction of external calcium concentration and verapamil on the effects of doxorubicin (adriamycin) in the isolated heart preparation. Journal of Cardiovascular Pharmacology. 5: 848-855. PMID 6195475 DOI: 10.1097/00005344-198309000-00022  0.321
1982 Rabkin SW, Mathewson FAL, Tate RB. The electrocardiogram in apparently healthy men and the risk of sudden death British Heart Journal. 47: 546-552. PMID 6177327 DOI: 10.1136/Hrt.47.6.546  0.348
1981 Rabkin SW, Mathewson FA, Tate RB. Relationship of ventricular ectopy in men without apparent heart disease to occurrence of ischemic heart disease and sudden death. American Heart Journal. 101: 135-142. PMID 7468414 DOI: 10.1016/0002-8703(81)90655-4  0.335
1981 Rabkin SW, Mathewson FAL, Tate RB. The relationship of marked left axis deviation to the risk of ischemic heart disease International Journal of Cardiology. 1: 169-178. PMID 7338420 DOI: 10.1016/0167-5273(81)90030-9  0.331
1981 Ohmae M, Rabkin SW. Hyperkalemia‐induced bundle branch block and complete heart block Clinical Cardiology. 4: 43-46. PMID 7226590 DOI: 10.1002/Clc.4960040110  0.309
1981 Morris AL, Rabkin SW, Ayotte B, Sharma GP. Role of the pericardium and intact chest wall in the hemodynamic response to positive end-expiratory pressure ventilation Canadian Journal of Physiology and Pharmacology. 59: 45-52. PMID 7011509 DOI: 10.1139/Y81-008  0.327
1981 Ohmae M, Rabkin SW, Fung HYM. Effect of angiotensin-converting enzyme inhibition by captopril on cardiac output, coronary blood flow, and systemic arterial blood pressure in the intact and in the bilaterally nephrectomized rabbit. Journal of Cardiovascular Pharmacology. 3: 1060-1067. PMID 6168851 DOI: 10.1097/00005344-198109000-00016  0.364
1980 Rabkin SW, Mathewson FAL, Tate RB. Chronobiology of Cardiac Sudden Death in Men Jama: the Journal of the American Medical Association. 244: 1357-1358. PMID 7411810 DOI: 10.1001/Jama.1980.03310120045023  0.34
1980 Rabkin SW, Mathewson FAL, Tate RB. Natural history of left bundle-branch block British Heart Journal. 43: 164-169. PMID 6444828 DOI: 10.1136/Hrt.43.2.164  0.342
1979 Rabkin SW, Mathewson FAL, Tate RB. Longitudinal blood pressure measurements during a 26-year observation period and the risk of ischemic heart disease American Journal of Epidemiology. 109: 650-662. PMID 453185 DOI: 10.1093/Oxfordjournals.Aje.A112728  0.336
1978 Rabkin SW, Mathewson FAL, Tate RB. Long term changes in blood pressure and risk of cerebrovascular disease Stroke. 9: 319-326. PMID 675743 DOI: 10.1161/01.Str.9.4.319  0.319
1978 Rabkin SW, Mathewson FAL, Tate RB. The relation of blood pressure to stroke prognosis Annals of Internal Medicine. 89: 15-20. PMID 666180 DOI: 10.7326/0003-4819-89-1-15  0.312
1978 Rabkin SW, Mathewson FAL, Tate RB. Predicting risk of ischemic heart disease and cerebrovascular disease from systolic and diastolic blood pressures Annals of Internal Medicine. 88: 342-345. PMID 629496 DOI: 10.7326/0003-4819-88-3-342  0.348
1977 Rabkin SW, Mathewson FAL, Tate RB. Prognosis after acute myocardial infarction: Relation to blood pressure values before infarction in a prospective cardiovascular study The American Journal of Cardiology. 40: 604-610. PMID 910724 DOI: 10.1016/0002-9149(77)90077-7  0.34
1977 Hsu PH, Mathewson FAL, Abu-Zeid HAH, Rabkin SW. Change in risk factor and the development of chronic disease. A methodological illustration Journal of Chronic Diseases. 30: 567-584. PMID 903389 DOI: 10.1016/0021-9681(77)90056-X  0.321
1977 Rabkin SW, Mathewson FAL, Hsu PH. Relation of body weight to development of ischemic heart disease in a cohort of young north American men after a 26 year observation period: The manitoba study The American Journal of Cardiology. 39: 452-458. PMID 842466 DOI: 10.1016/S0002-9149(77)80104-5  0.337
1977 Hsu PH, Mathewson FAL, Rabkin SW. Blood pressure and body mass index patterns-A longitudinal study Journal of Chronic Diseases. 30: 93-113. PMID 838840 DOI: 10.1016/0021-9681(77)90078-9  0.317
Show low-probability matches.